{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:36:54Z","timestamp":1790811414296,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology Clinics of North America"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.gtc.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:55:07Z","timestamp":1737708907000},"page":"277-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"54","author":[{"given":"Samantha J.","family":"Magier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Morley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen R.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gtc.2024.12.002_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1053\/j.gastro.2020.01.006","article-title":"AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis","volume":"158","author":"Feuerstein","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib2","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Inflammatory bowel disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.gtc.2024.12.002_bib3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(15)00465-1","article-title":"Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study","volume":"387","author":"Cleynen","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.gtc.2024.12.002_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for intestinal bacteria, viruses, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib5","first-page":"20","article-title":"FMT: what's next? A narrative review of fecal microbiota transplantation in clostridioides difficile infection and inflammatory bowel disease","volume":"105","author":"Patwa","year":"2022","journal-title":"R\u00a0I Med J (2013)"},{"key":"10.1016\/j.gtc.2024.12.002_bib6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2468-1253(22)00358-2","article-title":"Management of inflammatory bowel diseases in older adults","volume":"8","author":"Singh","year":"2023","journal-title":"The lancet Gastroenterology & hepatology"},{"key":"10.1016\/j.gtc.2024.12.002_bib7","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1053\/j.gastro.2021.04.023","article-title":"AGA technical review on the medical management of moderate to severe luminal and perianal fistulizing Crohn's disease","volume":"160","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2024.01.008","article-title":"AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases","volume":"166","author":"Peery","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib9","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","volume":"4","author":"Imdad","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.gtc.2024.12.002_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.gtc.2024.12.002_bib11","article-title":"Fecal microbial transplantation versus mesalamine enema for treatment of active left-sided ulcerative colitis-results of a randomized controlled trial","volume":"10","author":"B\u0159ezina","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.gtc.2024.12.002_bib12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.gtc.2024.12.002_bib13","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2015.04.001","article-title":"Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial","volume":"149","author":"Moayyedi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12876-021-01856-9","article-title":"Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study","volume":"21","author":"Crothers","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.gtc.2024.12.002_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S2468-1253(21)00400-3","article-title":"Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial","volume":"7","author":"Haifer","year":"2022","journal-title":"The lancet Gastroenterology & hepatology"},{"issue":"1","key":"10.1016\/j.gtc.2024.12.002_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12934-021-01513-6","article-title":"Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study","volume":"20","author":"Fang","year":"2021","journal-title":"Microb Cell Factories"},{"key":"10.1016\/j.gtc.2024.12.002_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/ecco-jcc\/jjab165","article-title":"Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the CRAFT UC randomised controlled trial","volume":"16","author":"Sarbagili Shabat","year":"2022","journal-title":"Journal of Crohn's & colitis"},{"key":"10.1016\/j.gtc.2024.12.002_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/j.gastro.2021.04.067","article-title":"Results of the first pilot randomized controlled trial of fecal microbiota transplant in pediatric ulcerative colitis: lessons, limitations, and future prospects","volume":"161","author":"Pai","year":"2021","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.gtc.2024.12.002_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplant on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.gtc.2024.12.002_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40168-020-0792-5","article-title":"Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study","volume":"8","author":"Sokol","year":"2020","journal-title":"Microbiome"},{"key":"10.1016\/j.gtc.2024.12.002_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s00384-023-04354-4","article-title":"Fecal microbiota transplantation for induction of remission in Crohn's disease: a systematic review and meta-analysis","volume":"38","author":"Zhou","year":"2023","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.gtc.2024.12.002_bib23","doi-asserted-by":"crossref","first-page":"otaa034","DOI":"10.1093\/crocol\/otaa034","article-title":"A\u00a0systematic review of fecal microbiota transplant for the management of pouchitis","volume":"2","author":"Kayal","year":"2020","journal-title":"Crohn's & colitis 360"},{"key":"10.1016\/j.gtc.2024.12.002_bib24","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1053\/j.gastro.2018.12.001","article-title":"Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis","volume":"156","author":"Paramsothy","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fmicb.2016.00713","article-title":"The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation","volume":"7","author":"Engels","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gtc.2024.12.002_bib26","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ibd.21606","article-title":"Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host","volume":"17","author":"Strauss","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2024.12.002_bib27","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3322","article-title":"New concepts in the generation and functions of IgA","volume":"12","author":"Pabst","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.gtc.2024.12.002_bib28","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","article-title":"Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease","volume":"158","author":"Palm","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.gtc.2024.12.002_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2021.09.061","article-title":"Transferable immunoglobulin A-coated odoribacter splanchnicus in responders to fecal microbiota transplantation for ulcerative colitis limits colonic inflammation","volume":"162","author":"Lima","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gtc.2024.12.002_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/MIB.0000000000001132","article-title":"Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis","volume":"23","author":"Jacob","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gtc.2024.12.002_bib31","article-title":"Short-term surveillance of cytokines and C-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.gtc.2024.12.002_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/nu15153340","article-title":"The underlying changes in serum metabolic profiles and efficacy prediction in patients with extensive ulcerative colitis undergoing fecal microbiota transplantation","volume":"15","author":"Wu","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.gtc.2024.12.002_bib33","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41467-018-07359-8","article-title":"Therapeutic faecal microbiota transplantation controls intestinal inflammation through IL10 secretion by immune cells","volume":"9","author":"Burrello","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.gtc.2024.12.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105803","article-title":"Fecal microbiota transplantation improves intestinal inflammation in mice with ulcerative colitis by modulating intestinal flora composition and down-regulating NF-kB signaling pathway","volume":"173","author":"Li","year":"2022","journal-title":"Microb Pathog"},{"key":"10.1016\/j.gtc.2024.12.002_bib35","doi-asserted-by":"crossref","first-page":"21536","DOI":"10.1073\/pnas.1922189117","article-title":"Defined microbiota transplant restores Th17\/ROR\u03b3t(+) regulatory T\u00a0cell balance in mice colonized with inflammatory bowel disease microbiotas","volume":"117","author":"Britton","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.gtc.2024.12.002_bib36","article-title":"The role of Th17 cells in inflammatory bowel disease and the research progress","volume":"13","author":"Chen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.gtc.2024.12.002_bib37","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1128\/JB.00118-11","article-title":"Draft genome sequences of six Escherichia coli isolates from the stepwise model of emergence of Escherichia coli O157:H7","volume":"193","author":"Rump","year":"2011","journal-title":"J\u00a0Bacteriol"},{"key":"10.1016\/j.gtc.2024.12.002_bib38","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","article-title":"Disease-specific alterations in the enteric virome in inflammatory bowel disease","volume":"160","author":"Norman","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.gtc.2024.12.002_bib39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s40168-022-01275-2","article-title":"Transplantation of bacteriophages from ulcerative colitis patients shifts the gut bacteriome and exacerbates the severity of DSS colitis","volume":"10","author":"Sinha","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.gtc.2024.12.002_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.chom.2019.01.008","article-title":"Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis","volume":"25","author":"Gogokhia","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.gtc.2024.12.002_bib41","article-title":"Repeated fecal microbial transplantations and antibiotic pre-treatment are linked to improved clinical response and remission in inflammatory bowel disease: a systematic review and pooled proportion meta-analysis","volume":"10","author":"Mocanu","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.gtc.2024.12.002_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40168-020-00991-x","article-title":"Antibiotic-associated dysbiosis affects the ability of the gut microbiota to control intestinal inflammation upon fecal microbiota transplantation in experimental colitis models","volume":"9","author":"Strati","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.gtc.2024.12.002_bib43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.gtc.2024.12.002_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.102611","article-title":"Mucosal microbial load in Crohn's disease: a potential predictor of response to faecal microbiota transplantation","volume":"51","author":"Sarrabayrouse","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gtc.2024.12.002_bib45","first-page":"779","article-title":"[Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial]","volume":"55","author":"Reinshagen","year":"2017","journal-title":"Zeitschrift fur Gastroenterologie"},{"key":"10.1016\/j.gtc.2024.12.002_bib46","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41467-024-46983-5","article-title":"Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice","volume":"15","author":"Luu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.gtc.2024.12.002_bib47","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2282789","article-title":"Loss of claudin-3 expression increases colitis risk by promoting Gut Dysbiosis","volume":"15","author":"Ahmad","year":"2023","journal-title":"Gut Microb"},{"key":"10.1016\/j.gtc.2024.12.002_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.159406","article-title":"Low-dose IL-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation","volume":"7","author":"Tchitchek","year":"2022","journal-title":"JCI insight"},{"key":"10.1016\/j.gtc.2024.12.002_bib49","first-page":"33","article-title":"C-X-C motif chemokine ligand 1 promotes colitis by modulating the gut microbiota","volume":"16","author":"Zhao","year":"2024","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.gtc.2024.12.002_bib50","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1080\/15548627.2020.1847460","article-title":"ESRRA (estrogen related receptor alpha) is a critical regulator of intestinal homeostasis through activation of autophagic flux via gut microbiota","volume":"17","author":"Kim","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.gtc.2024.12.002_bib51","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1001\/jama.2018.20046","article-title":"Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial","volume":"321","author":"Costello","year":"2019","journal-title":"JAMA"}],"container-title":["Gastroenterology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855324000918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889855324000918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T11:48:59Z","timestamp":1746791339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889855324000918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0889855324000918"],"URL":"https:\/\/doi.org\/10.1016\/j.gtc.2024.12.002","relation":{},"ISSN":["0889-8553"],"issn-type":[{"value":"0889-8553","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing Therapeutic Potential of Fecal Transplant in Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gtc.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}